Name | Title | Contact Details |
---|---|---|
Luke Denver |
Associate Director, Supply Chain Planning | Profile |
Maureen Secord |
Director, Clinical Supply Chain | Profile |
Sunil Joseph |
Director, Technology Business Partner, Clinical Research and Development Sciences | Profile |
Ellen Lopresti |
Chief People Officer | Profile |
Jill Donovan |
Associate Director, Talent Acquisition | Profile |
Skilled Care Pharmacy is a Mason, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The process that we follow for all projects is simple: we translate real-world experiences into expert advice. Whether this is through consulting or software applications, we align our entire organization to help you solve the specifics of challenges faced. When organizations engage with Y Prime, they have a dedicated support team that never changes. The people you work with from Day 1 will be there until completion of your project – no “knowledge transfers,” or redundant personnel required.
Bristol Meyers Squibb Company is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Windtree Therapeutics, Inc. is advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders to treat patients in moments of crisis. Using new clinical approaches, Windtree is developing a multi-asset franchise anchored around compounds with an ability to activate SERCA2a, with lead candidate istaroxime being developed as a first-in-class treatment for acute heart failure and early cardiogenic shock in heart failure. Windtree has also focused on developing AEROSURF® as a non-invasive surfactant treatment for premature infants with respiratory distress syndrome, and is facilitating transfer of clinical development of AEROSURF® to its licensee in Asia, Lee`s HK, while Windtree evaluates other uses for its synthetic KL4 surfactant for the treatment of acute pulmonary conditions including lung injury due to viral, chemical and radiation induced insults. Also, in its portfolio is rostafuroxin, a novel precision drug product targeting hypertensive patients with certain genetic profiles.
This is the website of PHC Holdings Corporation, which is a global innovator in healthcare solutions.